Explore our latest research, peer-reviewed publications, and official press announcements.
16 Results
FeaturedJournal of Digital Health — QA Test
This sample publication explores how digital health tools can support patient monitoring, improve access to information, and help healthcare teams review patient-reported outcomes.
Key finding
Digital tools may support consistent tracking and communication when appropriately designed and implemented.
FeaturedLandmark 24-month study of over 2,100 patients shows EcoAI™ delivers long-term pain relief and functional improvement with zero adverse events.
Key finding
a. 187,930 self-administered sessions across 2,100 adults with chronic pain. b. Median pain scores dropped from 4.1 at baseline to 1.9 after 24 months. c. Responder rates (patients with stable or improved symptoms) ranged between 66% and 71%, sustained over two years. d. Quality-of-life metrics: mood, function, social engagement, work activity, improved significantly (p < 0.01). e. Optimal use: 2 - 4 sessions daily, 20 - 59 minutes each; older adults (≥60) showed the highest compliance and benefit. f. Zero adverse events reported in nearly 188,000 sessions, underscoring EcoAI’s safety in home-based use.
Clinical Technology Review — QA Test
This sample record describes the potential use of digital technology to organize patient monitoring information.
Key finding
Digital records can help organize information for review.
EcoAI, an AI-guided TENS+EMS platform, significantly improved muscle weakness, fatigue, and spasms, with greater pain reduction in users who adhered more consistently. It demonstrated strong safety with no device-related adverse events, supporting its effectiveness as a real-world neuromuscular and pain management solution.
AI and remote monitoring can fundamentally shift chronic pain care away from reactive, opioid-dependent models toward personalized, data-driven relief. This editorial covers real-world clinical outcomes, Remote Therapeutic Monitoring (RTM) reimbursement codes, and the policy steps needed to scale these innovations equitably.
This research article explores how lifestyle, socioeconomic, and behavioral factors shape chronic pain experiences in a community-based adult sample. Findings support integrated, lifestyle-oriented approaches to care, emphasizing exercise, nutrition, and early intervention as key to reducing pain burden and improving quality of life.
.jpeg&w=3840&q=75)
This research article examines 24-month real-world outcomes of the EcoAI platform across 2,050 adults, with a focus on subgroup-level findings across age, gender, and activity level. EcoAI provided clinically meaningful, durable pain relief with improved function and mood, supporting personalized home-based neuromodulation as a safe, effective adjunct for chronic musculoskeletal pain.
Real-World Effectiveness of EcoAI, an FDA-Cleared Non-Invasive Neuromodulation Platform for Chronic Pain: 24-Month Analysis of Over 2,000 Patients
Artificial Intelligence–Enhanced Pain Management: The NXTSTIM EcoAI™ Platform
Transforming Chronic Pain Management: Integrating Neuromodulation with Remote Patient Monitoring with Advanced Technologies to Tackle Cognitive Dysfunction – A Narrative Review
Journal of Pain Research
24-Month Data Validates EcoAI's Long-Term Impact
Key finding
24-Month Data Validates EcoAI's Long-Term Impact (May, 2025)
Latest Advancements in Transcutaneous Electrical Nerve Stimulation (TENS) and Electronic Muscle Stimulation (EMS): Revisiting an Established Therapy with New Possibilities
Beyond the Pain Management Clinic: The Role of AI-Integrated Remote Patient Monitoring in Chronic Disease Management – A Narrative Review
18-Month Real world data on EcoAI (July, 2024)
NXTSTIM Shares Real-World Outcomes from EcoAI, Its FDA-Cleared Pain Management Platform
NXTSTIM Launches Real-World Registry to Track Outcomes for AI-Powered Closed-Loop Pain Management
Follow us on social media for real-time updates or reach out directly to start a conversation with the NXTSTIM team.
Featured